FDA, Cardiac Safety Research Consortium, and International Life Sciences Institute Host Public Workshop on Alternative Arrhythmia Risk Assessment Method

Summary

The FDA, Cardiac Safety Research Consortium, and International Life Sciences Institute will host a public workshop on July 23, 2013, to discuss a new paradigm for assessing Torsade de Pointes risk during drug development, potentially replacing clinical Thorough QT studies.